Global Triptans Products, Pipelines, Players, Patents And Prospects Report 2013

DUBLIN, Nov. 19, 2013 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/875wx5/triptans) has announced the addition of the "Global Triptans Products, Pipelines, Players, Patents and Prospects Report 2013" report to their offering.

(Logo: http://photos.prnewswire.com/prnh/20130307/600769)

Triptans consist of a class of drugs called selective 5-hydroxytryptamine subtype 1 (5-HT1) receptor agonists. Migraine headaches are an established and growing market for patient-friendly drug delivery. Triptans constrict blood vessels in the brain and relieve swelling, a mechanism that is thought to provide palliative relief to migraine patients, but also have other properties that may help treat migraine symptoms.

Worldwide, the highest prevalence of migraine occurs in North America. It is approximately 25 percent less frequent in Europe and Central and South America and approximately 67 percent less frequent in Asia and Africa. Most patients with migraine begin having the headaches in childhood, adolescence or early adulthood.

The market and growth prospects for migraine therapeutics are substantial and have attracted an expanding list of players.

Highlights

• Analyzes and evaluates triptan drug classes and products and development-stage candidates and assesses risks and market potential
• Provides assessments of indications and markets for triptans and examines key market and commercialization factors
• Evaluates the impact of economic, technology, and regulatory factors on triptan drug commercialization
• Provides market data and forecasts to 2018
• Profiles market sector participants, their product development activities and business strategies

Key Topics Covered:

Executive Summary

The Market Opportunity

Market Dynamics

• Indications and Prescribing
• Demand Drivers
• Competitive Landscape
• Risks and Opportunities

Triptan Drug Classes

• Almotriptans
• Eletriptans
• Frovatriptans
• Naratriptans
• Rizatriptans
• Sumatriptans
• Zolitriptans

Triptan Drug Products - Analysis, Market Data and Forecasts

• Almotriptans
• Branded Drugs
• Patents & Exclusivity
• Generics Outlook
• Eletriptans
• Branded Drugs
• Patents & Exclusivity
• Generics Outlook
• Frovatriptans
• Branded Drugs
• Patents & Exclusivity
• Generics Outlook
• Naratriptans
• Branded Drugs
• Patents & Exclusivity
• Generics Outlook
• Rizatriptans
• Branded Drugs
• Patents & Exclusivity
• Generics Outlook
• Sumatriptans
• Branded Drugs
• Patents & Exclusivity
• Generics Outlook
• Zopitriptans
• Branded Drugs
• Patents & Exclusivity
• Generics Outlook
  

Market Factors

Regulatory Issues

• Patient Compliance and Ease of Use
• Healthcare Economics

Company Profiles

For more information visit http://www.researchandmarkets.com/research/875wx5/triptans

About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Laura Wood , +353-1-481-1716, [email protected]

SOURCE Research and Markets